All posts tagged
Acute Myeloid Leukemia
UPDATE: Norwegian Stock Exchange could see Record Biotech IPO
UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy gets ready for Clinical Trials
Better and Safer Bone Marrow Transplants for Leukemia enter Phase III
French Biotech’s Checkpoint Inhibitor Fails Phase II Leukemia Trial
“We want to be the Worldwide Leader in Microbiota”
How is European Immuno-Oncology fighting Blood Cancer?
Celyad’s Autologous CAR-T Therapy enters Phase Ib
Red Blood Cells as Cancer Drug Carriers: Market Approval gets Delayed
How Good was 2015 for the French Universal CAR-T Biotech?
Swedish Investment loses €8M over failed Phase I/II for Leukemia
18-year-old French Hybrigenics goes to the US with its Acute Myeloid Leukemia Treatment
Labiotech UG, All Rights Reserved -
Send this to friend